The crazy thing about any of the covid trials, is

The crazy thing about any of the covid trials, is how the endpoints almost seem dated by the time they're done. I think cydy chose endpts that would really grab the world's attention(imo), but by the time enrollment was achieved and then 28 days pass, it seems like typical outcomes continue to move the bar. If I would have guessed at the beginning of the cd-12 trial, I would have thought mortality (in the placebo group) could have been 20-25%, but now, I think it will be much lower...5-7% anybody have any guesses? (I know that seems morbid, but that's the metric we have to showcase LL's potential. And of course less morbidity IS a good thing even if it makes LL seem less impressive.)